Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis

Research in Veterinary Science

Volumn 85, Issue 1, 2008, Pages 106-112

  Giunchetti, Rodolfo Cordeiro ^a,b   Reis, Alexandre Barbosa ^a,b   da Silveira Lemos, Denise ^b   Martins Filho, Olindo Assis ^b   Corrêa Oliveira, Rodrigo ^b   Bethony, Jeffrey ^b   Vale, André Macedo ^c   da Silva Quetz, Josiane ^c   Bueno, Lilian Lacerda ^c   França Silva, João Carlos ^c   Nascimento, Evaldo ^c   Mayrink, Wilson ^c   Fujiwara, Ricardo Toshio ^b,c  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Canine visceral leishmaniasis; Dog; Vaccine; Whole parasite vaccine

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LEISHMANIA VACCINE; PLACEBO;

ANIMAL CELL; ANIMAL PARASITOSIS; ANTIGENICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOG; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; LEISHMANIASIS; NONHUMAN; PARASITE CONTROL; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; DOG DISEASES; DOGS; IMMUNOGLOBULIN G; LEISHMANIA; LEISHMANIASIS, VISCERAL; LYMPHOCYTES; PROTOZOAN VACCINES;

CANIDAE; CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA INFANTUM; PROTOZOA;

EID: 43649083892     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.09.008     Document Type: Article

References (39)

1. Abranches P., Santos-Gomes G., Rachamim N., Campino L., Schnur L.F., and Jaffe C.L. An experimental model for canine visceral leishmaniasis. Parasite Immunology 13 (1991) 537-550
2. Baneth G., and Shaw S.E. Chemotherapy of canine leishmaniosis. Veterinary Parasitology 106 (2002) 315-324
3. Borja-Cabrera G.P., Correia Pontes N.N., Silva V.O., Paraguai de Souza E., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., and Palatnik de Sousa C.B. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). Vaccine 20 (2002) 3277-3284
4. Campos-Neto A., Porrozzi R., Greeson K., Coler R.N., Webb J.R., Seiky Y.A., Reed S.G., and Grimaldi G.Jr. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infection and Immunity 69 (2001) 4103-4108
5. Chabalgoity J.A., Moreno M., Carol H., Dougan G., and Hormaeche C.E. Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine. Vaccine 19 (2001) 460-469
6. Day M.J. Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation. Veterinary parasitology 147 (2007) 2-8
7. Deane L.M., and Deane M.P. Visceral leishmaniasis in Brazil. Geographical distribution and transmission. Revista do Instituto de Medicina Tropical de São Paulo 4 (1962) 149-212
8. Dole V.S., Raj V.S., Ghosh A., Madhubala R., Myler P.J., and Stuart K.D. Immunization with recombinant LD1 antigens protects against experimental leishmaniasis. Vaccine 15 (2000) 423-430
9. Evans T.G., Vasconcelos I.A.B., Lima J.W., Teixeira J.M., McAullife I.T., Lopes U.G., Pearson R.D., and Vasconcelos A.W. Canine visceral leishmaniosis in northeast Brazil: assessment of serodiagnostic methods. The American journal of Tropical Medicine and Hygiene 42 (1990) 118-123
10. Fujiwara R.T., Bueno L.L., Vale A.M., França-Silva J.C., Costa R.T., Quetz J.S., Machado-Coelho G.L., Reis A.B., Martins-Filho O.A., Genaro O., Nascimento E., and Mayrink W. Flow cytometric assay in peripheral blood of dogs - reference values for leukocytes from Brazilian Beagles. Polish Journal of Veterinary Sciences 8 (2005) 17-22
11. Fujiwara R.T., Vale A.M., França-Silva J.C., Costa R.T., Quetz J.S., Martins-Filho O.A., Reis A.B., Corrêa-Oliveira R., Machado-Coelho G.L., Bueno L.L., Bethony J.M., Frank G., Nascimento E., Genaro O., Mayrink W., Reed S., and Campos-Neto A. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis. Veterinary Research 36 (2005) 827-838
12. Fujiwara R.T., Loukas A., Mendez S., Williamson A.L., Bueno L.L., Wang Y., Samuel A., Zhan B., Bottazzi M.E., Hotez P.J., and Bethony J.M. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine 24 (2006) 501-509
13. Giunchetti R.C., Mayrink W., Genaro O., Carneiro C.M., Corrêa-Oliveira R., Martins-Filho O.A., Marques M.J., Tafuri W.L., and Reis A.B. Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. Journal of Comparative Pathology 135 (2006) 100-107
14. Giunchetti C., Martins-Filho O.A., Carneiro C.M., Mayrink W., Marques M.J., Tafuri W.L., Correa-Oliveira R., and Reis A.B. Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis. Veterinary Immunology and Immunopathology (2007) 10.1016/j.vetimm.2007.07.009
15. Giunchetti R.C., Mayrink W., Carneiro C.M., Correa-Oliveira R., Martins-Filho O.A., Marques M.J., Tafuri W.L., and Reis A.B. Histopathological and immunohistochemical investigations of the hepatic compartment associated with parasitism and serum biochemical changes in canine visceral leishmaniasis. Research in Veterinary Science (2007) 10.1016/j.rvsc.2007.04.020
16. Giunchetti R.C., Corrêa-Oliveira R., Martins-Filho O.A., Teixeira-Carvalho A., Roatt B.M., Aguiar-Soares R.D.O., Vitoriano-Souza J., Moreira N.D., Malaquias L.C.C., Castro L.L.M., Lana M., and Reis A.B. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Vaccine (2007) 10.1016/j.vaccine.2007.08.009
17. Gradoni L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Veterinary Parasitology 100 (2001) 87-103
18. Hommel M., Jaffe C.L., Travi B., and Milton G. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Annals of Tropical Medicine and Parasitology 89 (1995) 55-73
19. Khamesipour A., Rafati S., Davoudi N., Maboudi F., and Modabber F. Leishmaniasis vaccine candidates for development: a global overview. The Indian Journal of Medical Research 123 (2006) 423-438
20. Loukas A., Bethony J.M., Mendez S., Fujiwara R.T., Goud G.N., Ranjit N., Zhan B., Jones K., Bottazzi M.E., and Hotez P.J. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS medicine 2 (2005) 1008-1017
21. Lasri S., Sahibi H., Sadak A., Jaffe C.L., and Rhalem A. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. Veterinary Research 30 (1999) 441-449
22. Lemesre J., Holzmuller P., Cavaleyra M., Gonçalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
23. Mayrink W., Genaro O., Franca-Silva J.C., da Costa R.T., Tafuri W.F., Toledo V.P., da Silva A.R., Reis A.B., Williams P., and da Costa P.W. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Memórias do Instituto Oswaldo Cruz 91 (1996) 695-697
24. Molano I., Garci{dotless}́a-Alonso M., Mirón C., Redondo E., Requena J.M., Soto M., Gómez-Nieto C., and Alonso C. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Veterinary Immunology and Immunopathology 92 (2003) 1-13
25. Noli C., and Auxilia S.T. Treatment of canine Old World visceral leishmaniasis: a systematic review. Veterinary Dermatology 16 (2005) 213-232
26. Nunes M.P., Jackson J.M., Carvalho R.W., Furtado N.J., and Coutinho S.G. Serological survey for canine cutaneous and visceral leishmaniosis in area at risk for transmission in Rio de Janeiro where prophylactic measures had been adapted. Memórias do Instituto Oswaldo Cruz 86 (1991) 411-417
27. Panaro M.A., Acquafredda A., Lisi S., Lofrumento D.D., Mitolo V., Sisto M., Fasanella A., Trotta T., Bertani F., Consenti B., and Brandonisio O. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Comparative Immunology, Microbiology and Infectious Diseases 24 (2001) 187-195
28. Ravindran R., and Ali N. Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis. Current Molecular Medicine 4 (2004) 697-709
29. Reis A.B., Carneiro C.M., Carvalho M.G., Teixeira-Carvalho A., Giunchetti R.C., Mayrink W., Genaro O., Correa-Oliveira O.A., and Martins-Filho O.A. Establishment of a microplate assay for fow cytometric assessment and its use for the evaluation of age-related phenotypic changes in canine whole blood leukocytes. Veterinary Immunology and Immunopathology 103 (2005) 173-185
30. Reis A.B., Martins-Filho O.A., Teixeira-Carvalho A., Carvalho M.G., Mayrink W., França-Silva J.C., Giunchetti R.C., Genaro O., and Corrêa-Oliveira R. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Research in Veterinary Science 81 (2006) 68-75
31. Reis A.B., Teixeira-Carvalho A., Giunchetti R.C., Guerra L.L., Carvalho M.G., Mayrink W., Genaro O., Corrêa-Oliveira R., and Martins-Filho O.A. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Clinical and Experimental Immunology 146 (2006) 303-311
32. Reis A.B., Teixeira-Carvalho A., Vale A.M., Marques M.J., Giunchetti R.C., Mayrink W., Guerra L.L., Andrade R.A., Corrêa-Oliveira R., and Martins-Filho O.A. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Veterinary Immunology and Immunopathology 112 (2006) 102-116
33. Requena J.M., Iborra S., Carrión J., Alonso C., and Soto M. Recent advances in vaccines for leishmaniasis. Expert Opinion on Biological Therapy 4 (2004) 1505-1517
34. Rosario E.Y., Genaro O., Franca-Silva J.C., da Costa R.T., Mayrink W., Reis A.B., and Carneiro M. Evaluation of enzyme-linked immunosorbent assay using crude Leishmania and recombinant antigens as a diagnostic marker for canine visceral leishmaniasis. Memórias do Instituto Oswaldo Cruz 2 (2005) 197-203
35. Silva V.O., Borja-Cabrera G.P., Correia-Pontes N.N., Paraguai de Souza E., Luz K.G., Palatnik M., and Palatnik de Sousa C.B. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN). Vaccine 19 (2001) 1082-1092
36. + memory T cells: functional differentiation and homeostasis. Immunological Reviews 211 (2006) 39-48
37. Webb J.R., Kaufmann D., Campos-Neto A., and Reed S.G. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. Journal of Immunology 157 (1996) 5034-5041
38. Webb J.R., Campos-Neto A., Ovendale P.J., Martin T.I., Stromberg E.J., Badaró R., and Reed S.G. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infection and Immunity 66 (1998) 3279-3289
39. Wilson M.E., Young B.M., Andersen K.P., Weinstock J.V., Metwali A., Ali K.M., and Donelson J.E. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infection and Immunity 63 (1995) 2062-2069